Trials / Unknown
UnknownNCT01922687
Amlodipine Plus/Minus Atorvastatin for Protection of Arteries
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 109 (estimated)
- Sponsor
- Shanghai Institute of Hypertension · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to test the hypothesis that amlodipine plus atorvastatin given in a single tablet (Caduet), compared with amlodipine alone (Norvasc), has a stronger effect in protection of arterial structure and function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | amlodipine plus atorvastatin (Caduet) | |
| DRUG | amlodipine (Norvasc) |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2014-03-01
- Completion
- 2014-12-01
- First posted
- 2013-08-14
- Last updated
- 2013-08-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01922687. Inclusion in this directory is not an endorsement.